Hiroshi Hayashi

This inventor holds 9 USPTO granted patents. Top assignees: Asahi Kasei Kogyo Kabushiki Kaisha, Dainippon Pharmaceutical Company, Limited. Active years: 1978-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Hayashi. Retrieved from https://idiyas.com/inventor/hiroshi-hayashi-wundtrx1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 177(Granted Patents)

Location History:

Fuji, JA (1978)
Fuji, JP (1983 - 1993)
Shizuoka, JP (1993)

Company Filing History:

9 out of 1,297

Asahi Kasei Kogyo Kabushiki Kaisha

patents

3 out of 129

Dainippon Pharmaceutical Company, Limited

patents

where one patent can have more than one assignee

Years Active: 1978-1993

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5204327 - Treatment of cerebral edema with ANP pharmaceutical compositions (1993-04-20),

2. 5190750 - Methods for the treatment of demyelinating disease, uveitis, or (1993-03-02),

3. 4880915 - Method for purifying a physiologically active substance produced by (1989-11-14),

4. 4529594 - Protein having antitumor activity (1985-07-16),

5. 4457916 - Method for stabilizing Tumor Necrosis Factor and a stable aqueous (1984-07-03),

6. 4447355 - Method for stabilizing a tumor necrosis factor and a stable aqueous (1984-05-08),

7. 4409105 - Dried, sterilized, gamma-globulin-fixed column and a process for (1983-10-11),

8. 4393225 - AI-77 Compounds and pharmaceutically acceptable salts thereof (1983-07-12),

9. 4097665 - Diacylnucleosides and process for preparing the same (1978-06-27),

Title: Hiroshi Hayashi: Innovator in Pharmaceutical Compositions

Introduction

Hiroshi Hayashi is a notable inventor based in Fuji, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of severe medical conditions. With a total of 9 patents to his name, Hayashi's work has had a profound impact on medical science.

Latest Patents

Among his latest patents, Hayashi has developed a pharmaceutical composition for the treatment of cerebral edema. This composition includes an atrial natriuretic peptide with an amino acid sequence of 28 amino acids, combined with at least one pharmaceutically acceptable carrier, diluent, or excipient. Additionally, he has created a method for treating severe chronic inflammatory diseases, such as demyelinating disease and uveitis. This composition utilizes tumor necrosis factor as an active ingredient, along with suitable carriers or excipients.

Career Highlights

Hiroshi Hayashi has worked with prominent companies in the pharmaceutical industry, including Asahi Kasei Kogyo Kabushiki Kaisha and Dainippon Pharmaceutical Company, Limited. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking innovations in medicine.

Collaborations

Throughout his career, Hayashi has collaborated with esteemed colleagues, including Takao Kiyota and Torao Ishida. These partnerships have fostered an environment of innovation and have led to the development of impactful pharmaceutical solutions.

Conclusion

Hiroshi Hayashi's contributions to the field of pharmaceuticals are noteworthy, with his innovative patents addressing critical health issues. His work continues to influence the medical community and improve patient outcomes.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]